The CCND1 G870A Gene Polymorphism and Brain Tumor Risk: a Meta-analysis |
Qin, Ling-Yan
(Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University)
Zhao, Li-Gang (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Chen, Xu (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Li, Ping (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Yang, Zheng (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Mo, Wu-Ning (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) |
1 | Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. DOI ScienceOn |
2 | Evan GI, Vousden KH (2001). Proliferation, cell cycle and apoptosis in cancer. Nature, 411, 342-8. DOI ScienceOn |
3 | Galbraith RF (1988). A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med, 7, 889-94. DOI ScienceOn |
4 | Gazioglu NM, Erensoy N, Kadioglu P, et al (2007). Altered cyclin D1 genotype distribution in human sporadic pituitary adenomas. Med Sci Monit, 13, 457-63. |
5 | Inskip PD, Linet MS, Heineman EF (1995). Etiology of brain tumors in adults. Epidemiol Rev, 17, 382-414. |
6 | Kong S, Amos CI, Luthra R, et al (2000). Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res, 60, 249-52. |
7 | Liu J, Liao Q, Zhang Y, et al (2012). Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis. Tumour Biol, 33, 1467-76. DOI |
8 | Betticher DC, Thatcher N, Altermatt HJ, et al (1995). Alternate splicing produces a novel cyclin D1 transcript. Oncogene, 11, 1005-11. |
9 | Akkiz H, Bayram S, Bekar A, et al (2010). Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: casecontrol study. Cancer Epidemiol, 34, 298-302. DOI ScienceOn |
10 | Bala S, Peltomaki P (2001). CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res, 61, 6042-5. |
11 | Bedewy AM, Mostafa MH, Saad AA, et al (2013). Association of cyclin D1 A870G polymorphism with two malignancies:acute lymphoblastic leukemia and breast cancer. J BUON, 18, 227-38. |
12 | Bondy ML, Scheurer ME, Malmer B, et al (2008). Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer, 113, 1953-68. DOI ScienceOn |
13 | Cander S, Erturk E, Karkucak M, et al (2012). Effect of cycline D1 (CCND1) gene polymorphism on tumor formation and behavior in patients with prolactinoma. Gene, 509, 158-63. DOI ScienceOn |
14 | Chen B, Cao L, Yang P, et al (2012). Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20, 271 subjects. Cancer Epidemiol, 36, 106-15. DOI ScienceOn |
15 | Chen X, Zhao T, Li L, et al (2012). CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population. DNA Cell Biol, 31, 1107-13. DOI ScienceOn |
16 | Zeybek U, Yaylim I, Ozkan NE, et al (2013). Cyclin D1 gene G870A variants and primary brain tumors. Asian Pac J Cancer Prev, 14, 4101-6. 과학기술학회마을 DOI ScienceOn |
17 | Wang L, Habuchi T, Mitsumori K, et al (2003). Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism. Int J Cancer, 103, 116-20. DOI ScienceOn |
18 | Wang Y, Li Z, Liu N, et al (2014). Association between CCND1 and XPC polymorphisms and bladder cancer risk: a metaanalysis based on 15 case-control studies. Tumour Biol, 35, 3155-65. DOI ScienceOn |
19 | Yang Y, Wang F, Shi C, et al (2012). Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies. Plos One, 7, 36813. DOI |
20 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
21 | Qiuling S, Yuxin Z, Suhua Z, et al (2003). Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population. Carcinogenesis, 24, 1499-503. DOI ScienceOn |
22 | Solomon DA, Wang Y, Fox SR, et al (2003). Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem, 278, 30339-47. DOI ScienceOn |
23 | Rajaraman P, Wang SS, Rothman N, et al (2007). Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev, 16, 1655-61. DOI ScienceOn |
24 | Sherr CJ (1995). D-type cyclins. Trends Biochem Sci, 20, 187-90. DOI ScienceOn |
25 | Simpson DJ, Fryer AA, Grossman AB, et al (2001). Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas. Carcinogenesis, 22, 1801-7. DOI ScienceOn |
26 | Stuck AE, Rubenstein LZ, Wieland D (1998). Bias in metaanalysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ, 316, 469. DOI ScienceOn |
27 | Tobias A, Campbell MJ (1999). Modelling influenza epidemics in the relation between black smoke and total mortality. A sensitivity analysis. J Epidemiol Community Health, 53, 583-4. DOI |
28 | Vogelstein B, Kinzler KW (2004). Cancer genes and the pathways they control. Nat Med, 10, 789-99. DOI ScienceOn |
29 | Donnellan R, Chetty R (1998). Cyclin D1 and human neoplasia. Mol Pathol, 51, 1-7. DOI ScienceOn |
30 | Daly AF, Rixhon M, Adam C, et al (2006). High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab, 91, 4769-75. DOI |
31 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. DOI ScienceOn |
32 | Diehl JA (2002). Cycling to cancer with cyclin D1. Cancer Biol Ther, 1, 226-31. DOI |
33 | Sadetzki S, Flint-Richter P, Starinsky S, et al (2005). Genotyping of patients with sporadic and radiationassociated meningiomas. Cancer Epidemiol Biomarkers Prev, 14, 969-76. DOI ScienceOn |
34 | Catarino R, Coelho A, Nogueira A, et al (2012). Cyclin D1 polymorphism in non-small cell lung cancer in a Portuguese population. Cancer Biomark, 12, 65-72. |
35 | Gijtenbeek JM, Boots-Sprenger SH, Franke B, et al (2005). Cyclin D1 genotype and expression in sporadic hemangioblastomas. J Neurooncol, 74, 261-6. DOI |